Alpha Tau Medical Ltd

DRTS

Company Profile

  • Business description

    Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.

  • Contact

    Kiryat HaMada Street 5
    Jerusalem9777605
    ISR

    T: +972 35774115

    https://www.alphatau.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    121

Stocks News & Analysis

stocks

ASX growth share with attractive dividend

Worries about AI overblown.
stocks

Higher fair value for undervalued wide moat share

Investors are overly concerned with upcoming capital expenditures.
stocks

Fears of deteriorating loan quality sends bank share plummeting

We maintain our fair value estimate despite unfavourable economic conditions.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,026.9046.300.52%
CAC 408,367.3317.54-0.21%
DAX 4024,626.8944.33-0.18%
Dow JONES (US)52,196.26320.150.62%
FTSE 10010,484.2223.80-0.23%
HKSE23,026.68354.821.57%
NASDAQ25,800.67503.051.99%
Nikkei 22569,468.11107.230.15%
NZX 50 Index13,545.5650.320.37%
S&P 5007,437.8083.781.14%
S&P/ASX 2008,823.4046.500.53%
SSE Composite Index4,073.9046.641.16%

Market Movers